021-51111890
购物车（）
sales@molnova.cn
N-Formyl-Met-Leu-Phe-Lys
CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys ( fMLFK )
产品货号. M22300 CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys (fMLFK) 是一种肽，作为 FPR1 的有效选择性激动剂，对 FPR1、FPR2 和 FPR2-D2817.32G 的 EC50 分别为 3.5 nM、6.7 μM 和 0.88 μM，分别。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1017 | 有现货 |
|
| 10MG | ￥1482 | 有现货 |
|
| 25MG | ￥2306 | 有现货 |
|
| 50MG | ￥3060 | 有现货 |
|
| 100MG | ￥4077 | 有现货 |
|
| 200MG | ￥5499 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称N-Formyl-Met-Leu-Phe-Lys
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述N-Formyl-Met-Leu-Phe-Lys (fMLFK) 是一种肽，作为 FPR1 的有效选择性激动剂，对 FPR1、FPR2 和 FPR2-D2817.32G 的 EC50 分别为 3.5 nM、6.7 μM 和 0.88 μM，分别。
-
产品描述N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.Chemotactic peptide (fMLFK) binds specifically to receptors on leukocyte membranes. Uptake of chemotactic peptides can contribute to quantitative assessment of neutrophils in localized inflammatory processes and is independent of associated edema formation or microcirculatory compromise.
-
体外实验——
-
体内实验——
-
同义词fMLFK
-
通路Others
-
靶点Other Targets
-
受体FPR1|FPR2
-
研究领域——
-
适应症——
化学信息
-
CAS Number67247-11-4
-
分子量565.73
-
分子式C27H43N5O6S
-
纯度>98% (HPLC)
-
溶解度H2O
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
(S)-Mephenytoin
(S)-Mephenytoin ((+)-Mephenytoin) 抗惊厥作用。它是细胞色素 P450 (CYP) 同工型 CYP2C19 的底物，可用于分析细胞色素 P450 代谢。
-
ATI-2341 TFA
ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.ATI-2341 is an effective mobilization agent for myeloid polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs).
-
Imupedone
Imupedone (LF 1695) is a synthetic immunomodulator that modulates T lymphocytes and macrophages, induces T-cell differentiation of bone marrow precursor cells, and increases the proliferative response of lymphocytes to mitogens, antigens, and allogeneic cells.CAS ??13483-84-5
